Elotuzumab and daratumumab: emerging new monoclonal antibodies for multiple myeloma.

Expert review of anticancer therapy

Volumn 13, Issue 9, 2013, Pages 1081-1088

  Kuroda, Junya ^a   Nagoshi, Hisao ^b   Shimura, Yuji ^b   Taniwaki, Masafumi ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DARATUMUMAB; ELOTUZUMAB; MONOCLONAL ANTIBODY;

BONE MARROW; DRUG EFFECTS; HUMAN; IMMUNOTHERAPY; MULTIPLE MYELOMA; PROCEDURES; STROMA CELL;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE MARROW; HUMANS; IMMUNOTHERAPY; MULTIPLE MYELOMA; STROMAL CELLS;

EID: 84896527916     PISSN: None     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2013.829641     Document Type: Review

References (0)